DyNAbind and Salipro Biotech Enter Collaboration Agreement
9 Dec 2020
DyNAbind GmbH and Salipro Biotech AB are teaming up to tackle drug discovery against challenging membrane protein targets!
Proteros Biostructures and X-Chem to Offer Comprehensive Joint Target-to-Lead Drug Discovery Services
1 Oct 2020
Proteros Biostructures GmbH (Proteros) and X-Chem, Inc. (X-Chem) announced today the launch of an alliance with the goal of offering Hit-Identification and Target-to-Lead drug discovery services based on their complementary technology platforms.
DNA Encoded Compound Library
7 Jul 2020
In recent years, the biopharmaceutical industry has been undergoing some fundamental changes and transformation. These changes are underlined by the unwavering demands for great medicines to treat serious illness in both developed and developing countries, which highlight the urgent need for the biopharmaceutical industry to foster greater innovation, and to focus on developing various drug candidates.
Join Our Newsletter for Free
